When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CHMA - Chiasma's Mycapssa successful in late-stage acromegaly study; shares up 30% premarket
Chiasma Inc.
Thinly traded micro cap Chiasma (NASDAQ:CHMA) is up 30% premarket on increased volume in response to positive results from a Phase 3 clinical trial, OPTIMAL, evaluating Mycapssa (octreotide) for the maintenance treatment of adults with acromegaly, a hormone disorder characterized by enlarged bone growth in the hands, feet and face.
More news on: Chiasma, Inc., Healthcare stocks news, Stocks on the move,